Eli Lilly & Co
LLY- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000059478
In the last 90 days, Eli Lilly & Co insiders filed 0 open-market purchases and 3 sales; 4,643 institutions reported holding it in 13F filings for Q2 2026, worth $942.7B in total; 4 superinvestors hold it, including ARK Invest and Soros Fund Management.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Eli Lilly & Co insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 3 filings
- 3 insiders, $16.0M in total
- Insiders trading
- 3
- Net value
- −$16.0M
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Eli Lilly & Co, current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Sulzberger Gabrielle | Director | 3,012 | Sep 22, 2026 | 12 |
| Luciano Juan R | Director | 16,957 | Sep 22, 2026 | 12 |
| Fyrwald J Erik | Director | 75,536 | Sep 22, 2026 | 12 |
| Alvarez Ralph | Director | 55,838 | Sep 22, 2026 | 12 |
| Seymour Melissa | EVP, Global Quality | 1,038 | Sep 11, 2026 | 2 |
| Hernandez Edgardo | EVP & Pres., Mfg. Operations | 46,083 | Sep 4, 2026 | 3 |
| Dozier Eric | EVP, Chief People Officer | 14,239 | Sep 4, 2026 | 4 |
| Jonsson Patrik | EVP & President, LLY Int'l | 54,147 | Aug 18, 2026 | 3 |
| Zakrowski Donald A | SVP, Finance, & CAO | 1,526 | Aug 11, 2026 | 4 |
| Hakim Anat | EVP, GC & Secretary | 11,875Indirect | Aug 10, 2026 | 3 |
| Yuffa Ilya | EVP&Pres, LLY USA&Global Capab | 29,804 | Jun 11, 2026 | 3 |
| Lilly Endowment Inc | Other: Former 10% Shareholder | 91,881,150 | May 7, 2026 | 34 |
| Montarce Lucas | EVP & CFO | 16,258 | Feb 18, 2026 | 2 |
| Custer Kenneth L. | EVP & President, Card Met Hlth | 10,141 | Feb 18, 2026 | 2 |
| Brown Adrienne S | EVP, President LLY Imm | 5,142 | Feb 18, 2026 | 2 |
| Rau Diogo | EVP & CIDO | 26,397 | Feb 12, 2026 | 2 |
| Ricks David A | President, Chair, and CEO | 571,715 | Feb 11, 2026 | 3 |
| Van Naarden Jacob | EVP,Pres LLY Oncology&HdCorpBD | 26,627 | Feb 11, 2026 | 2 |
| Skovronsky Daniel | EVP, CS&PO & Pres. LRL | 160,072 | Feb 11, 2026 | 3 |
| Hedley Mary Lynne | Director | 2,253 | Dec 16, 2025 | 3 |
| Moeller Jon R | Director | 304 | Nov 18, 2025 | 1 |
| Baicker Katherine | Director | 23,503 | Nov 18, 2025 | 1 |
| Kaelin William G Jr | Director | 21,837 | Nov 18, 2025 | 1 |
| Jackson Jamere | Director | 9,635 | Nov 18, 2025 | 1 |
| Johnson Kimberly H | Director | 3,265 | Nov 18, 2025 | 1 |
| White Anne E. | EVP & Pres, Lilly Neuroscience | 74,210 | Feb 12, 2025 | 0 |
| Walker Karen | Director | 6,249 | Nov 20, 2024 | 0 |
| Norton Johna | EVP, Global Quality | 25,428 | Jun 3, 2024 | 0 |
| Ashkenazi Anat | EVP & CFO | 42,330 | Feb 14, 2024 | 0 |
| Weems Alonzo | EVP, ERM & CECO | 7,951 | Feb 14, 2024 | 0 |
| Runge Marschall S | Director | 16,593 | Nov 21, 2023 | 0 |
| Tai Jackson P | Director | 63,524 | Apr 19, 2023 | 0 |
| Pusey Leigh Ann | EVP, Corp. Affairs & Comm. | 31,641 | Feb 14, 2023 | 0 |
| Mason Michael B | EVP & Pres., Lilly Diabetes | 39,284 | Feb 14, 2023 | 0 |
| Fry Stephen F | SVP, HR & Diversity | 152,631 | Feb 11, 2022 | 0 |
| Eskew Michael L | Director | 45,080 | Nov 17, 2021 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Oct 14, 2025 (view filing) | Oct 10 | 4 days | Lilly Endowment Inc10% Owner | SSale | −3.66K | $863.24 | −$3.16M | 0.0%94.5M after | 2 lots |
| Nov 3, 2025 (view filing) | Oct 31 | 3 days | Lilly Endowment Inc10% Owner | SSale | −301.3K | $863.35 | −$260.2M | −0.3%94.2M after | 8 lots |
| Nov 4, 2025 (view filing) | Nov 3 | 1 day | Lilly Endowment Inc10% Owner | SSale | −300.0K | $888.83 | −$266.6M | −0.3%93.9M after | 24 lots |
| Nov 5, 2025 (view filing) | Nov 4 | 1 day | Lilly Endowment Inc10% Owner | SSale | −526 | $910.72 | −$479.0K | 0.0%93.9M after | |
| Nov 6, 2025 (view filing) | Nov 5 | 1 day | Lilly Endowment Inc10% Owner | SSale | −179.0K | $933.26 | −$167.1M | −0.2%93.8M after | 30 lots |
| Nov 6, 2025 (view filing) | Nov 5 | 1 day | Lilly Endowment Inc10% Owner | SSale | −40.4K | $951.56 | −$38.5M | 0.0%93.7M after | 8 lots |
| Nov 12, 2025 (view filing) | Nov 10 | 2 days | Lilly Endowment Inc10% Owner | SSale | −16.9K | $972.52 | −$16.4M | 0.0%93.7M after | 3 lots |
| Nov 12, 2025 (view filing) | Nov 11 | 1 day | Lilly Endowment Inc10% Owner | SSale | −283.1K | $986.64 | −$279.3M | −0.3%93.4M after | 27 lots |
| Nov 13, 2025 (view filing) | Nov 12 | 1 day | Lilly Endowment Inc10% Owner | SSale | −305.0K | $1,011.19 | −$308.4M | −0.3%93.1M after | 20 lots |
| Nov 13, 2025 (view filing) | Nov 13 | Same day | Zakrowski Donald ASVP, Finance, & CAO | SSale | −1.00K | $1,010.50 | −$1.01M | −26.0%2.84K after | 10b5-1 |
| Nov 14, 2025 (view filing) | Nov 13 | 1 day | Lilly Endowment Inc10% Owner | SSale | −46.6K | $1,030.26 | −$48.0M | −0.1%93.1M after | 2 lots |
| Nov 17, 2025 (view filing) | Nov 14 | 3 days | Lilly Endowment Inc10% Owner | SSale | −178.3K | $425,738.48 | −$75.9B | −0.2%92.9M after | 4 lotsPrice outlier |
| Nov 18, 2025 (view filing) | Nov 17 | 1 day | Lilly Endowment Inc10% Owner | SSale | −9.89K | $1,030.68 | −$10.2M | 0.0%92.9M after | 2 lots |
| Nov 19, 2025 (view filing) | Nov 18 | 1 day | Lilly Endowment Inc10% Owner | SSale | −60.2K | $1,034.78 | −$62.3M | −0.1%92.8M after | 10 lots |
| Nov 20, 2025 (view filing) | Nov 19 | 1 day | Lilly Endowment Inc10% Owner | SSale | −167.5K | $1,051.17 | −$176.1M | −0.2%92.6M after | 6 lots |
| Nov 21, 2025 (view filing) | Nov 20 | 1 day | Lilly Endowment Inc10% Owner | SSale | −37.1K | $1,051.66 | −$39.1M | 0.0%92.6M after | 6 lots |
| Nov 24, 2025 (view filing) | Nov 21 | 3 days | Lilly Endowment Inc10% Owner | SSale | −105.3K | $1,058.66 | −$111.5M | −0.1%92.5M after | 17 lots |
| Nov 25, 2025 (view filing) | Nov 24 | 1 day | Lilly Endowment Inc10% Owner | SSale | −142.3K | $1,068.53 | −$152.1M | −0.2%92.4M after | 6 lots |
| Nov 26, 2025 (view filing) | Nov 25 | 1 day | Lilly Endowment Inc10% Owner | SSale | −147.1K | $1,095.35 | −$161.1M | −0.2%92.2M after | 30 lots |
| Nov 26, 2025 (view filing) | Nov 25 | 1 day | Lilly Endowment Inc10% Owner | SSale | −15.6K | $1,109.30 | −$17.3M | 0.0%92.2M after | 3 lots |
| Dec 29, 2025 (view filing) | Dec 23 | 6 days | Lilly Endowment Inc10% Owner | SSale | −240 | $1,085.04 | −$260.4K | 0.0%92.2M after | |
| Dec 29, 2025 (view filing) | Dec 24 | 5 days | Lilly Endowment Inc10% Owner | SSale | −2.63K | $1,085.17 | −$2.85M | 0.0%92.2M after | |
| Dec 30, 2025 (view filing) | Dec 29 | 1 day | Lilly Endowment Inc10% Owner | SSale | −3.59K | $1,085.04 | −$3.90M | 0.0%92.2M after | |
| Jan 6, 2026 (view filing) | Jan 5 | 1 day | Lilly Endowment Inc10% Owner | SSale | −1.39K | $1,085.01 | −$1.51M | 0.0%92.2M after | |
| Jan 8, 2026 (view filing) | Jan 7 | 1 day | Lilly Endowment Inc10% Owner | SSale | −292.1K | $1,103.48 | −$322.4M | −0.3%91.9M after | 30 lots |
| May 7, 2026 (view filing) | May 6 | 1 day | Lilly Endowment IncOther: Former 10% Shareholder | SSale | −15.8K | $995.36 | −$15.8M | 0.0%91.9M after | 2 lots |
| Jun 11, 2026 (view filing) | Jun 10 | 1 day | Yuffa IlyaEVP&Pres, LLY USA&Global Capab | SSale | −2.50K | $1,150.77 | −$2.88M | −7.7%29.8K after | 10b5-1 |
| Aug 10, 2026 (view filing)4:19 PM ET | Aug 7 | 3 days | Hakim AnatEVP, GC & Secretary | SSale | −5.00K | $1,190.00 | −$5.95M | −29.6%11.9K after | 10b5-1 |
| Aug 11, 2026 (view filing)4:31 PM ET | Aug 10 | 1 day | Zakrowski Donald ASVP, Finance, & CAO | SSale | −2.00K | $1,185.01 | −$2.37M | −56.7%1.53K after | 10b5-1 |
| Aug 18, 2026 (view filing)4:20 PM ET | Aug 17 | 1 day | Jonsson PatrikEVP & President, LLY Int'l | SSale | −6.50K | $1,175.10 | −$7.64M | −10.7%54.1K after | 10b5-1 |